Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03352011 · ClinicalTrials.gov registry record · NA

Primary Care Brief Mindfulness Training for Veterans With PTSD

A NA study of Post Traumatic Stress Disorder, sponsored by Syracuse VA Medical Center.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT03352011: Completed NA study of Post Traumatic Stress Disorder, sponsored by Syracuse VA Medical Center.

NCT03352011 is a NA study of Post Traumatic Stress Disorder that has completed, run by Syracuse VA Medical Center. The registered enrollment target is 55 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03352011, a NA study of Post Traumatic Stress Disorder, has completed, sponsored by Syracuse VA Medical Center.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

The proposed study supports a line of research that seeks to improve the health of military veterans with post-traumatic stress disorder (PTSD) by teaching them mindfulness skills. The proposed study first gathers Veteran's Affairs mental health provider and peer support specialist feedback to adapt a brief mindfulness intervention and then investigates the feasibility of testing this intervention in a small randomized clinical trial. The study targets primary care patients with PTSD who may be reluctant to engage in other mental health treatments and provides them with mindfulness training to reduce PTSD symptoms, improve psychosocial functioning and increase hope for recovery.

Primary Outcome

rate of participants who complete all assessment time points

Interventions

  • BEHAVIORAL Primary Care Brief Mindfulness Training
  • BEHAVIORAL PTSD Psychoeducational Class

Study Locations (1)

New York

  • Syracuse Veterans Affairs Medical Center - Syracuse

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2018-01-02
Est. Completion 2020-06-17
Phase NA
Syracuse VA Medical Center

8 total trials

What the finished NCT03352011 record still lists

NCT03352011 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Primary Care Brief Mindfulness Training is the first listed.

NCT03352011 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03352011 about?

NCT03352011 is a clinical study titled "Primary Care Brief Mindfulness Training for Veterans With PTSD". The proposed study supports a line of research that seeks to improve the health of military veterans with post-traumatic stress disorder (PTSD) by teaching them mindfulness skills. The proposed study first gathers Veteran's Affairs mental health provider and peer support specialist feedback to adapt...

What is the current status of trial NCT03352011?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2018-01-02. Estimated completion is 2020-06-17.

What conditions does trial NCT03352011 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT03352011?

The interventions under investigation include: Primary Care Brief Mindfulness Training (BEHAVIORAL), PTSD Psychoeducational Class (BEHAVIORAL).

Who is sponsoring clinical trial NCT03352011?

This trial is sponsored by Syracuse VA Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03352011 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03352011's enrollment target sits among peer trials

55 171st of 262 higher than 91 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03352011, the US trial registry maintained by the National Library of Medicine. NCT03352011 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.